Bethan Hughes highlights some of the past year's key trends and events — from health-care reform to pharmaceutical company mega-mergers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The Henry J. Kaiser Family Foundation. Focus on Health Reform. Side-by-side comparison of major health care reform proposals. The Henry J. Kaiser Family Foundation website [online], (2009).
Nature Rev. Drug Discov. 8, 261–263 (2009).
Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and Congress. Department of Health and Human Services website [online], (2009).
Board on Health Care Services. Initial National Priorities for Comparative Effectiveness Research. Institute of Medicine of the National Academies website [online], (2009).
Nature Rev. Drug Discov. 8, 683–684 (2009).
Department for Business, Enterprise and Regulatory Reform. The Review and Refresh of Bioscience 2015. A Report to Government by the Bioscience Innovation and Growth Team. Department for Business, Enterprise and Regulatory Reform website [online], (2009).
Professor Sir Ian Kennedy. Appraising the value of innovation and other benefits. A short study for NICE. The NICE website [online], (2009).
Department of Health. A Consultation on proposals for the Innovation Pass pilot. Department of Health website [online], (2009).
Nature Rev. Drug Discov. 8, 692 (2009).
Nature Rev. Drug Discov. 7, 479–488 (2008).
Nature Biotech. 26, 985–990 (2008).
Committee for Medicinal Products for Human Use. Concept paper on the development of a guideline on similar biological medicinal products containing monoclonal antibodies. European Medicines Agency website [online], (2009).
Nature Rev. Drug Discov. 8, 181 (2009).
Nature Rev. Drug Discov. 8, 837 (2009).
Nature Rev. Drug Discov. 8, 927–928 (2009).
Nature Rev. Drug Discov. 8, 959–968 (2009).
Nature Rev. Drug Discov. 8, 523–524 (2009).
Innovative Medicines Initiative.IMI 2nd Call 2009. The IMI website [online], (2009).
Nature Rev. Drug Discov. 8, 344–345 (2009).
Rights and permissions
About this article
Cite this article
2009 in reflection. Nat Rev Drug Discov 9, 5–8 (2010). https://doi.org/10.1038/nrd3086
Issue Date:
DOI: https://doi.org/10.1038/nrd3086
